Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.
about
Molecular structure and expression of the murine lymphocyte low-affinity receptor for IgE (Fc epsilon RII)Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunizationHistory of interleukin-4Differential stimulation of immune function by respiratory and contact chemical allergensExtract of Nippostrongylus brasiliensis stimulates polyclonal type-2 immunoglobulin response by inducing De novo class switchInterleukin 4 induces membrane Thy-1 expression on normal murine B cellsDefective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4Induction of type 2 responses by schistosome worms during prepatent infection.Immunoglobulin switch circular DNA in the mouse infected with Nippostrongylus brasiliensis: evidence for successive class switching from mu to epsilon via gamma 1.Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma bruceiOntogeny of Th1 memory responses against a Brucella abortus conjugate.The road to the production of IgE is long and winding.Cytokine fingerprinting and hazard assessment of chemical respiratory allergy.IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gammaClinical application of NKT cell assays to the prediction of type 1 diabetes.Perinatal exposure to a low dose of bisphenol A impaired systemic cellular immune response and predisposes young rats to intestinal parasitic infection.The gene expression response of chronic lymphocytic leukemia cells to IL-4 is specific, depends on ZAP-70 status and is differentially affected by an NFκB inhibitor.Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy.Expansion of gamma delta+ T cells in BALB/c mice infected with Leishmania major is dependent upon Th2-type CD4+ T cells.Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis.Modulation of murine AIDS-related pathology by concurrent antibody treatment and coinfection with Leishmania majorInterleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells.Interleukin 4 expressed in situ selectively alters thymocyte developmentAnti-interferon gamma treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses.Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytesRegulation of the immune response to peptide antigens: differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotypeReplacement of germ-line epsilon promoter by gene targeting alters control of immunoglobulin heavy chain class switching.Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin 4 production by non-B, non-T cells.Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.Differential regulation of IgG1 and IgE synthesis by interleukin 4.Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell culturesReciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.Induction of human IgE synthesis by CD4+ T cell clones. Requirement for interleukin 4 and low molecular weight B cell growth factor.Evidence for mouse Th1- and Th2-like helper T cells in vivo. Selective reduction of Th1-like cells after total lymphoid irradiation.Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivoTherapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse.Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production.
P2860
Q24305317-0D3B3559-4CE2-4FE4-AA9F-BACD7BE451CEQ24599495-E9167725-113D-4C47-816F-678BB75C0F7EQ28085747-38781228-886B-4248-8BDD-B5ED75D9A129Q28327960-E63545B8-007A-49DD-A256-2DB0C326D851Q33597390-14C0108B-BFBD-4DC9-AD4A-A6CD0C35B939Q33641182-E376AA0E-2BB2-4854-8F48-DB31B6D3BA71Q33734319-6EB3DFD7-4EAE-476B-8CC5-678D7AFBC064Q33740902-CFE0BC87-28C6-415B-A0DD-DC41449DC128Q33834065-E548F067-A6C0-42DF-BF75-70F7336124DAQ34003340-0C196093-A1F2-4064-AAAD-74CCF111039BQ34008869-6F27FEF3-7E19-46E2-AB03-A869E09243E0Q34033732-72638ED2-9927-4052-A13F-65FB2BFCE2D1Q34208518-41326704-D799-4E20-8819-54FD795B1CA0Q34292243-C32DB223-28C3-44F9-B176-2075D4A061AFQ34470637-4DCD8433-6609-4DB1-800F-064C4503A2CBQ34557783-2148EB2B-70BD-4269-9698-D0F2B8FF40AEQ35299464-BB432B46-B02E-4C9C-90E4-9513B76A6090Q35382970-A8BDE74B-B690-49AC-8F44-A6C45514BCA8Q35428744-6BB43002-62C4-490F-B15B-232B0F7253D6Q35775408-FBC8DD7B-4831-47FC-B3F5-096B55433293Q35883083-718637E8-2457-40C3-9E26-2E5A9B6F49C0Q36107871-601A59E3-3243-4448-A5FE-F8BB60D6EE82Q36229764-86563472-B6A9-4363-B500-858106631201Q36229864-71D6DAC2-57D9-45B4-9B47-735C15E516DDQ36229974-B2EB4619-C4DC-4706-B94F-72A5885D7CB3Q36230442-60DC3B8F-4747-4AB4-901F-C8AD2240CA99Q36259698-F348D69E-FEA8-45B2-BDB9-ABA76CC99097Q36261169-C418E0D5-EC86-4891-9CE3-BE1BBD72B30AQ36350176-32694529-AD35-4C94-9B44-B4DCEB46F40CQ36351110-54608BED-9669-42F9-A72F-D9F3BA3CC397Q36353430-C6AD73CE-F09B-44D8-A005-D7330826BFFDQ36354355-B485E045-602D-4927-951D-8DF3A1193ADBQ36355282-9086A6AE-D8ED-4688-88A9-9E7999A2C924Q36355870-0918B4A8-0D25-4CF3-AA88-E9592836E2A6Q36356982-62A0D295-67A3-4A0B-9C35-75A1C0ED0ECDQ36357027-C53197B3-3B5C-4082-B816-78BD4B06978EQ36363260-ECFE574C-60DA-4D3E-BEB6-FC50D074E92DQ36366108-3923E766-8773-44D0-9030-62355608FBC3Q36367533-453B089D-B1D2-4863-8485-A688CE54FF84Q36380917-FE94363C-722E-4036-B8E9-DDB9DE8CE555
P2860
Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Suppression of in vivo polyclo ...... e B-cell stimulatory factor 1.
@en
Suppression of in vivo polyclo ...... e B-cell stimulatory factor 1.
@nl
type
label
Suppression of in vivo polyclo ...... e B-cell stimulatory factor 1.
@en
Suppression of in vivo polyclo ...... e B-cell stimulatory factor 1.
@nl
prefLabel
Suppression of in vivo polyclo ...... e B-cell stimulatory factor 1.
@en
Suppression of in vivo polyclo ...... e B-cell stimulatory factor 1.
@nl
P2093
P2860
P356
P1476
Suppression of in vivo polyclo ...... ne B-cell stimulatory factor 1
@en
P2093
C M Snapper
F D Finkelman
I M Katona
P2860
P304
P356
10.1073/PNAS.83.24.9675
P407
P577
1986-12-01T00:00:00Z